Literature DB >> 6982285

Antinuclear antibody-negative systemic lupus erythematosus-how common?

K C McHardy, C H Horne, J Rennie.   

Abstract

A review of five years' DNA-binding antibody results in a routine service laboratory revealed 38 patients who had high DNA-binding capacity (DNA-bc) but no antinuclear antibodies (ANA). On retrospective case note analysis, 22 patients (58%) were thought to have systemic lupus erythematosus (SLE), although only six (16%) fulfilled the preliminary classification criteria of the American Rheumatism Association (ARA). Our findings indicate that ANA-negative SLE is commoner than generally realised and lead us to recommended the measurement of DNA-bc in every case where clinically appropriate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982285      PMCID: PMC497894          DOI: 10.1136/jcp.35.10.1118

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  Antinuclear antibody tests as a clinically selected screening procedure.

Authors:  B A Bartholomew
Journal:  Am J Clin Pathol       Date:  1974-04       Impact factor: 2.493

2.  Neuropsychiatric problems in systemic lupus erythematosus.

Authors:  R Bennett; G R Hughes; E G Bywaters; P J Holt
Journal:  Br Med J       Date:  1972-11-11

3.  Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women.

Authors:  W J Fessel
Journal:  Arch Intern Med       Date:  1974-12

Review 4.  The natural history of systemic lupus erythematosus by prospective analysis.

Authors:  D Estes; C L Christian
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

5.  Criteria for classification of S.L.E.

Authors:  P Davis; B Atkins; R G Josse; G R Hughes
Journal:  Br Med J       Date:  1973-07-14

6.  Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid.

Authors:  R T Wold; F E Young; E M Tan; R S Farr
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

7.  Measurement of serum DNA-binding activity in systemic lupus erythematosus.

Authors:  T Pincus; P H Schur; J A Rose; J L Decker; N Talal
Journal:  N Engl J Med       Date:  1969-09-25       Impact factor: 91.245

8.  Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide.

Authors:  G R Hughes; S A Cohen; C L Christian
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

9.  Nervous system involvement in systemic lupus erythematosus.

Authors:  T Gibson; A R Myers
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

10.  Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus.

Authors:  J Holian; I D Griffiths; D N Glass; R N Maini; J T Scott
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

View more
  7 in total

1.  Detection of anti-dsDNA as a diagnostic tool.

Authors:  K C McHardy; J A Rennie; I M Reid; C H Horne
Journal:  Ann Rheum Dis       Date:  1985-08       Impact factor: 19.103

2.  Pattern of antinuclear antibody and antiextractable nuclear antigen antibody test requisitions in Riyadh.

Authors:  Najla Ali Alghabban; Zahid Shakoor
Journal:  J Family Med Prim Care       Date:  2019-11-15

3.  Positive Antinuclear Antibody (ANA)-Negative Systemic Lupus Erythematosus (SLE) Presenting With Acute Pancreatitis.

Authors:  Joydeep Samanta; Souveek Mitra; Kaushik Sen; Avishek Saha
Journal:  Cureus       Date:  2022-03-10

4.  Hematological Manifestations of SLE at Initial Presentation: Is It Underestimated?

Authors:  P K Sasidharan; M Bindya; K G Sajeeth Kumar
Journal:  ISRN Hematol       Date:  2012-07-09

5.  An antinuclear antibody-negative patient with lupus nephritis.

Authors:  Hyoun Ah Kim; Jae Wook Chung; Han Jung Park; Dai Yeol Joe; Hyun Ee Yim; Hae Sim Park; Chang Hee Suh
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 2.884

6.  Kozhikode criteria for diagnosing systemic lupus erythematosus as a hematological disorder.

Authors:  N Arathi; P K Sasidharan; P Geetha
Journal:  J Blood Med       Date:  2016-03-08

7.  Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis.

Authors:  May Y Choi; Jing Cui; Karen Costenbader; David Rydzewski; Lisa Bernhard; Peter Schur
Journal:  Lupus Sci Med       Date:  2020-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.